SelectScience InterviewsLife Sciences

Achieve Higher RBC Recoveries with the Acrodisc Syringe Filter

5 Aug 2014
Achieve Higher RBC Recoveries with the Acrodisc Syringe Filter

Watch this interview to learn more about the Acrodisc WBC isolation syringe filter that contains Pall’s patented and proven Leukosorb® media, a fibrous matrix that is specially designed for blood cell separation procedures. The Effective Filtration Area (EFA) enables faster filtration and separation of the sample, which translates to very low hold up volumes.

Acrodisc® WBC Syringe Filter

Pall Life Sciences - Laboratory, Food, Beverage

Pall Life Sciences' Acrodisc WBC premium syringe filter is an innovative filtration device designed specifically for use in the capture and recovery of Leukocytes and the separation of red blood cells. The Acrodisc WBC filter contains Pall's patented Leukosorb media. Leukosorb is a fibrous matrix that uses a multimodal approach of size exclusion and adsorption to capture and recover leukocytes from whole blood samples while allowing Red Blood Cells (RBCs) and platelets to flow through the membrane. With the Acrodisc WBC, the uniquely designed filter does all the difficult capture work, resulting in more efficient white blood cell separation as compared to Buffy Coat density gradient methods. The Acrodisc WBC yields greater cell capture and recovery with less sample compared to larger filter formats and also exudes very low hold up volume as compared to larger white blood cell isolation filters (hold up volume   Applications: Antigenic specificity Antigen modulation studies Cell receptor analysis Lymphocyte recovery for cell therapy Stem cell research applications  

(0)

Other videos from Pall Life Sciences - Laboratory, Food, Beverage

Links

Achieve Higher RBC Recoveries with the Acrodisc Syringe Filter